Breast Cancer, Eye Movement Desensitization and Processing, Psychoterapy
Conditions
Keywords
Breast Cancer, EMDR
Brief summary
The study will consist in an adjustment/adaptation of the "standard EMDR protocol" for cancer disease, and most particulary for women who present a breast cancer and during adjuvant therapy. It will also test the faisability of the research, with a view to adjust the calendar and the ressources to put at disposal for a randomized control trial that follow. This study will also allow to test the need and acceptibility of this new psychotherapy for the patient, and to identify facilitators and obstacles : participation/rejection ratio, inclusion rythm, adhesion of the medical staff about the project
Interventions
BEHAVIORALEMDR psychotherapy
Visit 0 : patient inclusion (questionnaires and interview) Visit 1 : anamnesis Visit 2 : patient supporting Visit 3 : EMDR psychotherapy care Visit 4 : EMDR psychotherapy care Visit 5 : EMDR psychotherapy care and questionnaires Visit 6 : EMDR psychotherapy care Visit 7 : EMDR psychotherapy care Visit 8 : EMDR psychotherapy care ans questionnaires Visit 9 (one month after) : semi-directive interview and data recovery (questionnaires)
Sponsors
Centre Hospitalier Régional Metz-Thionville
University of Lorraine
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
All the women will receive the same intervention.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Being a woman aged of 18 years or more * Having a primary invasive breast cancer * Having undergo a mastectomy for a primary invasive breast cancer * Being able to complete the questionnaires * Being informed of the study and having signed the informed consent * Being affiliated to a welfare system
Exclusion criteria
* having contraindications to recieve EMDR psychotherapy (neurologic disorders, dissociatif states, oculomotor issues) * Having started adjuvant treatments following surgery * Having metastatic breast cancer * Presenting physical polypathologies * Having psychiatric antecedents (included anxiety and depressif disorders - assessed with M.I.N.I. (Sheehan and al., 1997)). * Having drug or alcohol addiction * Being placed under the safeguard of justice, guardianship or trusteeship * Being pregnant or breast-feeding
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| patients involvement | week 12 | acceptability of the new psychotherapy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| adequacy of the intervention with the field | Week 12 | adaptability of the EMDR protocol |
| EMDR psychotherapy efficacy during the study, we will survey our population several times with differents questionnaires | Week 12 | ratio of patients which wants to participate and effectively participate |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORRafaele Longo, Dr
CHR Metz-Thionville
Outcome results
None listed